Use of eRF1 mutants in unnatural amino acid incorporation

Patent metadata

Field	Value
Publication number	US-10738339-B2
Application number	US-201515521103-A
Country	US
Kind code	B2
Filing date	Oct 21, 2015
Priority date	Oct 27, 2014
Publication date	Aug 11, 2020
Grant date	Aug 11, 2020

Abstract

The invention relates to a method for incorporating an unnatural amino acid into a protein of interest in a eukaryotic cell, said method comprising the steps of: i) providing a eukaryotic cell expressing an orthogonal tRNA synthetase-t RNA pair, a nucleic acid sequence of interest encoding said protein of interest, and a mutant eRF1, said mutant eRF1 having amino acid sequence having at least 60% sequence identity to the human wild type eRF1 sequence of SEQ ID NO: 4, said nucleic acid sequence of interest comprising a codon recognised by the tRNA at the position for incorporation of an unnatural amino acid; ii) incubating the eukaryotic cell in the presence of an unnatural amino acid to be incorporated into a protein encoded by the nucleic acid sequence of interest, wherein said unnatural amino acid is a substrate for the orthogonal tRNA synthetase; and iii) incubating the eukaryotic cell to allow incorporation of said unnatural amino acid into the protein of interest via the orthogonal tRNA synthetase-t RNA pair. The invention also relates to uses, host cells, combinations and kits.

First claim

The invention claimed is:

1. A method for incorporating an unnatural amino acid into a protein of interest in a eukaryotic cell, said method comprising the steps of:
providing a eukaryotic cell expressing an orthogonal tRNA synthetase-tRNA pair, a nucleic acid sequence of interest encoding said protein of interest, and a mutant eRF1, wherein said mutant eRF1 increases unnatural amino acid incorporation in response to one or more TAG (amber) stop codons without substantially increasing read-through of other stop codons, said mutant eRF1 having an amino acid sequence having at least 84.5% sequence identity to SEQ ID NO: 4, wherein said mutant eRF1 comprises an E55D mutation relative to SEQ ID NO: 4
said nucleic acid sequence of interest comprising a codon recognised by the tRNA at the position for incorporation of said unnatural amino acid;
b. incubating the eukaryotic cell in the presence of said unnatural amino acid to be incorporated into the protein of interest, wherein said unnatural amino acid is a substrate for the orthogonal tRNA synthetase; and
c. incubating the eukaryotic cell to allow incorporation of said unnatural amino acid into the protein of interest via the orthogonal tRNA synthetase-tRNA pair.

2. A method according to claim 1 , wherein said mutant eRF1 provides increased efficiency of unnatural amino acid incorporation relative to a wild type eRF1 control.

3. A method according to claim 1 , wherein said mutant eRF1 further comprises a mutation or combination of mutations relative to SEQ ID NO: 4 selected from the group consisting of
b. N129P, K130Q
c. T122Q, S123F
e. Y125F
f. T58K, S60T, S64D, Y125F, N129S
g. S123A, L124I, Y125L
h. S123R, L124W, Y125R
i. S123H, L124A, Y125G
j. M51A, K130M
k. S123A, L124L, Y125V
l. S123L, L124C, Y125S
m. S123L, L124S, Y125S, and
n. S123V, L124T, Y125P.

4. A method according to claim 1 , wherein said mutant eRF1 further comprises a mutation or combination of mutations relative to SEQ ID NO: 4 selected from the group consisting of
a.
b. N129, K130
d. Y125
e. T58, S60, S64, Y125, N129
f. S123, L124, Y125
g. S123, L124, Y125
h. S123, L124, Y125
i. M51, K130
j. S123, L124, Y125
k. S123, L124, Y125
l. S123, L124, Y125 and
m. 5123, L124, Y125.

5. A method according to claim 1 , wherein said eukaryotic cell is a mammalian or insect cell.

6. A method according to claim 1 , wherein said codon is a stop codon, and said stop codon is optionally UAG.

7. A method according to claim 1 , wherein the orthogonal tRNA synthetase-tRNA pair comprises a pyrrolysyl-tRNA synthetase (PylRS)/PylT tRNA CUA pair.

8. A method according to claim 1 , wherein the tRNA is:
a. a U25C variant of PylT, or
b. an Opt variant of PylT, or
c. a U25C-Opt variant of PylT.

9. A method according to claim 1 , wherein the unnatural amino acid is BocK, CypK or BCNK.

10. A method for incorporating an unnatural amino acid into a protein of interest in a eukaryotic cell, said method comprising the steps of:
a. providing a eukaryotic cell expressing an orthogonal tRNA synthetase-tRNA pair, a nucleic acid sequence of interest encoding said protein of interest, and a mutant eRF1, wherein said mutant eRF1 increases unnatural amino acid incorporation in response to one stop codon without substantially increasing read-through of other stop codons, said mutant eRF1 having an amino acid sequence having at least 84.5% sequence identity to SEQ ID NO: 4, wherein said mutant eRF1 comprises a mutation or combination of mutations relative to SEQ ID NO: 4 selected from the group consisting of:
i. N129P, K130Q
ii. T122Q, S123F
iii. E55A
iv. Y125F
v. T58K, S60T, S64D, Y125F, N129S
vi. S123A, L124I, Y125L
vii. S123R, L124W, Y125R
viii. S123H, L124A, Y125G
ix. M51A, K130M
x. S123A, L124L, Y125V
xi. S123L, L124C, Y125S
xii. S123L, L124S, Y125S
xiii. S123V, L124T, Y125P
said nucleic acid sequence of interest comprising a codon recognised by the tRNA at the position for incorporation of said unnatural amino acid;

b. incubating the eukaryotic cell in the presence of said unnatural amino acid to be incorporated into the protein of interest, wherein said unnatural amino acid is a substrate for the orthogonal tRNA synthetase; and
c. incubating the eukaryotic cell to allow incorporation of said unnatural amino acid into the protein of interest via the orthogonal tRNA synthetase-tRNA pair.

11. A method according to claim 10 , wherein said mutant eRF1 provides increased efficiency of unnatural amino acid incorporation relative to a wild type eRF1 control.

12. A method according to claim 10 , wherein said stop codon is TAG (amber).

13. A method according to claim 10 , wherein said eukaryotic cell is a mammalian or insect cell.

14. A method according to claim 10 , wherein said codon is a stop codon, and said stop codon is optionally UAG.

15. A method according to claim 10 , wherein the orthogonal tRNA synthetase-tRNA pair comprises a pyrrolysyl-tRNA synthetase (PylRS)/PylT tRNA CUA pair.

16. A method according to claim 10 , wherein the tRNA is:
a. a U25C variant of PylT, or
b. an Opt variant of PylT, or
c. a U25C-Opt variant of PylT.

17. A method according to claim 10 , wherein the unnatural amino acid is BocK, CypK or BCNK.

Assignees

• Res & Innovation Uk

Inventors

• Chin Jason W
• Schmied Wolfgang H
• Elsasser Simon J
• Kym Eugene Y

Classifications

• C12N15/67 Primary

  General methods for enhancing the expression · CPC title

• C07K14/47

  from mammals · CPC title

• C12Y601/01026

  Pyrrolysine-tRNAPyl ligase (6.1.1.26) · CPC title

• C12P21/02 Primary

  having a known sequence of two or more amino acids, e.g. glutathione · CPC title

• C12N9/93

  Ligases (6) · CPC title